Agomab Announces $89 Million Series D Financing, with the participation of Asabys, to Support Broad Fibrosis-focused Pipeline

by Asabys Partners

Agomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors as Asabys.

Read more

Asabys’ portfolio company Agomab Raises $100 Million Series C from Fidelity, EQT Life Sciences, Canaan and KKR

by Asabys Partners

Agomab Therapeutics NV ('Agomab') today announced the closing of a $100 million Series C round of financing to support the Phase 2a clinical trial evaluating Agomab's lead drug candidate, AGMB-129, a ...

Read more

ICF invests €10M in Asabys fund II, which has already 3 companies in its portfolio

by Asabys Partners

Asabys has announced that the Institut Català de Finances (ICF) has joined its new venture capital fund, Sabadell Asabys Health Innovation Investments II (Sabadell Asabys II), with 10 million euros. ...

Read more

La convergencia en la industria sanitaria: invertir en innovación y tecnología

by Asebio

En los últimos dos años hemos vivido una transformación en la industria sanitaria, viendo como dos grandes industrias, independientes y en constante evolución, se acercaban hasta acabar convergien...

Read more

Asabys invests in Israeli MedTech firm Medasense

by CATALONIA.HEALTH

Asabys Partners, a venture capital firm and member of CataloniaBio & HealthTech, has participated in Medasense Biometrics Ltd’s €15.2-million Series C round of funding along with investors such as...

Read more

Alantra enters venture capital via strategic partnership with Asabys Partners, a VC firm backed by Banc Sabadell

by Asabys Partners

Asabys Partners (“Asabys”), a Pan-European Venture Capital firm specialized in investments in the life sciences and health sectors, and Alantra, an investment banking and asset management firm...

Read more

Acuerdo de colaboración entre IQS y Asabys Partners

by IQS Institut Químic de Sarrià

Desde sus respectivos ámbitos de actividad, IQS y Asabys Partners comparten el reto de impulsar soluciones de futuro en las áreas de la salud, la biomedicina y la industria biofarmaceútica.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream